RUSHB:NASDAQRush Enterprises, Inc. Analysis
Data as of 2026-07-03 - not real-time
$75.08
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Rush Enterprises is trading firmly above its short‑term moving averages and the longer‑term average, with a bullish MACD crossover and RSI sitting in the upper‑mid range, suggesting continued upward momentum. Volume has been picking up, and the price is hovering near a key resistance level while a solid support zone lies comfortably below the current market price.
Fundamentally, the company faces a modest revenue decline and thin profit margins, but it generates healthy cash flow, carries a manageable debt load, and pays a modest dividend with a low payout ratio. The discounted cash‑flow model indicates a fair value well below the current market price, pointing to an overvalued situation despite the stable dividend and defensive balance sheet. The upcoming earnings call will be a critical catalyst for short‑term direction.
Fundamentally, the company faces a modest revenue decline and thin profit margins, but it generates healthy cash flow, carries a manageable debt load, and pays a modest dividend with a low payout ratio. The discounted cash‑flow model indicates a fair value well below the current market price, pointing to an overvalued situation despite the stable dividend and defensive balance sheet. The upcoming earnings call will be a critical catalyst for short‑term direction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical setup with price above key moving averages
- Elevated volatility and proximity to resistance
- Upcoming earnings announcement as a near‑term catalyst
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Fundamental overvaluation versus DCF fair value
- Stable dividend and solid cash generation
- Modest revenue contraction and thin margins
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Persistent revenue decline and limited growth outlook
- Current market price significantly above intrinsic value
- Cyclical exposure in the consumer sector with high volatility
Key Metrics & Analysis
Financial Health
Revenue Growth-9.00%
Profit Margin3.65%
P/E Ratio22.7
ROE11.93%
ROA5.22%
Debt/Equity62.65
P/B Ratio2.6
Op. Cash Flow$768.7M
Free Cash Flow$367.3M
Technical Analysis
TrendBullish
RSI63.3
Support$64.52
Resistance$76.90
MA 20$71.94
MA 50$69.67
MA 200$61.82
MACDBullish
VolumeIncreasing
Fear & Greed Index92.59
Valuation
Fair Value$46.90
GradeOvervalued
TypeValue
Dividend Yield1.01%
Risk Assessment
Beta0.78
Volatility28.21%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.